The prevalence, comorbidity and intensity of treatment of peripheral arterial disease in primary care. Results of the getABI study;Prävalenz, komorbidität und behandlungsintensität der peripheren arteriellen verschlusskrankheit in der hausarztpraxis: Ergebnisse der getABI-Studie

Gefasschirurgie

Volumn 9, Issue 3, 2004, Pages 166-171

  Allenberg, J R ^a   Trampisch, H J ^b   Darius, H ^c   Lange, S ^b   Haberl, R ^d   Stritzky, B V ^e   Tepohl, G ^f   Pittrow, D ^g   Diehm, C ^h  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c VIVANTES KLINIKUM NEUKÖLLN   (Germany)

^d Neurologische Abteilung   (Germany)

^e Medizinische Abteilung   (Germany)

^f Internist/Angiologie   (Germany)

^g DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^h UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Ankle brachial index; Atherothrombosis; Peripheral arterial disease; Prevalence; Risk factors; Screening

Indexed keywords

ANTITHROMBOCYTIC AGENT;

AGED; ARTERY DISEASE; ARTICLE; BODY MASS; CEREBROVASCULAR DISEASE; CLINICAL OBSERVATION; CLINICAL PRACTICE; COMORBIDITY; ELDERLY CARE; FEMALE; GENERAL PRACTICE; GERMANY; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PREVALENCE; PRIMARY MEDICAL CARE; SCREENING TEST; SECONDARY PREVENTION; THROMBOSIS;

EID: 4444295920     PISSN: 09487034     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00772-004-0360-5     Document Type: Article

References (21)

1. Antithrombotic Trialists' Collaboration (2002) Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324:71-86
2. Belch JJ, Topol EJ, Agnelli G et al. (2003) Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med 163:884-892
3. Bellach B-M, Hense H-W, Hoffmann W et al. (2000) Leitlinien und Empfehlungen zur Sicherung von Guter Epidemiologischer Praxis (GEP). Arbeitsgruppe Epidemiologische Methoden der Deutschen Arbeitsgemeinschaft Epidemiologie (DAE): http://www.gmds.de/texte/onlinedocs/empfehlungen/ empf_gep_langfassung.htm
4. CAPRIE Steering Committee (1996) A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348(9038):1329-1339
5. Criqui MH, Denenberg JO (1998) The generalized nature of atherosclerosis: how peripheral arterial disease may predict adverse events from coronary artery disease. Vasc Med 3/3:241-245
6. Darius H, Pittrow D, Haberl R et al. (2003) Are elevated homocysteine plasma levels related to peripheral arterial disease? Results from a cross-sectional study of 6,880 primary care patients. Eur J Clin Invest 33/9:751-757
7. Diehm C, Schuster A, Allenberg H, Darius H et al. (2004) High prevalence of peripheral arterial disease and comorbidity in 6,880 primary care patients: cross sectional study. Atherosclerosis 172:95-105
8. Dormandy J, Heeck L, Vig S (1999) Lower-extremity arteriosclerosis as a reflection of a systemic process: implications for concomitant coronary and carotid disease. Semin Vasc Surg 12/2:118-122
9. Dormandy J, Rutherford R (2000) Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 31(1Pt 2):1-296
10. Greenland P, Abrams J, Aurigemma GP et al. (2000) Prevention Conference V. Beyond secondary prevention: Identifying the high-risk patient for primary prevention. Noninvasive tests of atherosclerotic burden. Circulation 101/1:E16-22
11. Hirsch AT, Criqui MH, Treat-Jacobson D et al. (2001) Peripheral arterial disease detection, awareness, and treatment in primary care. J Am Med Ass 286/11:1317-1324
12. Kornitzer M, Dramaix M, Sobolski J, Degre S, De Backer G (1995) Ankle/arm pressure index in asymptomatic middle-aged males: an independent predictor of ten-year coronary heart disease mortality. Angiology 46/3: 211-219
13. Lange S, Darius H, Haberl R et al. (2003) Different methods for determination of the ankle brachial index influence the prevalence estimate of peripheral arterial disease. Annual Meeting of the International Epidemiological Association, Toledo, Spain
14. Lange S, Diehm C, Darius H et al. (2003) High prevalence of peripheral arterial disease but low antiplatelet treatment rates in elderly primary care patients with diabetes. Diabetes Care 26/12:3357-3358
15. McDermott M, Greenland P, Liu K et al. (2002) The ankle brachial index is associated with leg function and physical activity: the Walking and Leg Circulation Study. Ann Intern Med 136/12:873-883
16. McKenna M, Wolfson S, Kuller L (1991) Theratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis 87(2-3):119-128
17. Meijer WT, Hoes AW, Rutgers D, Bots ML, Hofman A, Grobbee DE (1998) Peripheral arterial disease in the elderly: The Rotterdam Study. Arterioscler Thromb Vasc Biol 18/2:185-192
18. Newman AB, Shemanski L, Manolio TA et al. (1999) Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. Arterioscler Thromb Vasc Biol 19/3:538-545
19. Papamichael CM, Lekakis JP, Stamatelopoulos KS et al. (2000) Ankle-brachial index as a predictor of the extent of coronary atherosclerosis and cardiovascular events in patients with coronary artery disease. Am J Cardiol 86/6:615-618
20. Trampisch HJ, Diehm C, Spengel FA et al. (2002) Wie gefährlich ist die asymptomatische pAVK? Cardiovasc 2 (Sonderheft 1):48-53
21. Zusman R, Chesebro J, Comerota A et al. (1999) Antiplatelet therapy in the prevention of ischemic vascular events: literature review and evidence-based guidelines for drug selection. Clin Cardiol 22/9:559-573